These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 20980590)

  • 41. Nicotine alters food-cue reactivity via networks extending from the hypothalamus.
    Kroemer NB; Guevara A; Vollstädt-Klein S; Smolka MN
    Neuropsychopharmacology; 2013 Oct; 38(11):2307-14. PubMed ID: 23778853
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A benefit-risk assessment of sibutramine in the management of obesity.
    Nisoli E; Carruba MO
    Drug Saf; 2003; 26(14):1027-48. PubMed ID: 14583064
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.
    Fekete EM; Inoue K; Zhao Y; Rivier JE; Vale WW; Szücs A; Koob GF; Zorrilla EP
    Neuropsychopharmacology; 2007 May; 32(5):1052-68. PubMed ID: 17019404
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Olanzapine and sibutramine have opposing effects on the motivation for palatable food.
    van der Zwaal EM; Janhunen SK; Luijendijk MC; Baclesanu R; Vanderschuren LJ; Adan RA; La Fleur SE
    Behav Pharmacol; 2012 Apr; 23(2):198-204. PubMed ID: 22327018
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sensory-specific satiety: food-specific reduction in responsiveness of ventral forebrain neurons after feeding in the monkey.
    Rolls ET; Murzi E; Yaxley S; Thorpe SJ; Simpson SJ
    Brain Res; 1986 Mar; 368(1):79-86. PubMed ID: 3955366
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thermogenic effects of sibutramine in humans.
    Hansen DL; Toubro S; Stock MJ; Macdonald IA; Astrup A
    Am J Clin Nutr; 1998 Dec; 68(6):1180-6. PubMed ID: 9846844
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contrasting effects of systemic and central sibutramine administration on the intake of a palatable diet in the rat.
    Pratt WE; Connolly ME
    Neurosci Lett; 2010 Oct; 484(1):30-4. PubMed ID: 20705119
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Brain regions where cholecystokinin suppresses feeding in rats.
    Blevins JE; Stanley BG; Reidelberger RD
    Brain Res; 2000 Mar; 860(1-2):1-10. PubMed ID: 10727618
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Amygdalo-hypothalamic circuit allows learned cues to override satiety and promote eating.
    Petrovich GD; Setlow B; Holland PC; Gallagher M
    J Neurosci; 2002 Oct; 22(19):8748-53. PubMed ID: 12351750
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Locomotion is the major determinant of sibutramine-induced increase in energy expenditure.
    Golozoubova V; Strauss F; Malmlöf K
    Pharmacol Biochem Behav; 2006 Apr; 83(4):517-27. PubMed ID: 16647108
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of sibutramine on resting metabolic rate and weight loss in overweight women.
    Seagle HM; Bessesen DH; Hill JO
    Obes Res; 1998 Mar; 6(2):115-21. PubMed ID: 9545017
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The discovery and status of sibutramine as an anti-obesity drug.
    Luque CA; Rey JA
    Eur J Pharmacol; 2002 Apr; 440(2-3):119-28. PubMed ID: 12007530
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sibutramine reduces food intake in non-dieting women with obesity.
    Rolls BJ; Shide DJ; Thorwart ML; Ulbrecht JS
    Obes Res; 1998 Jan; 6(1):1-11. PubMed ID: 9526964
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enantioselective behavioral effects of sibutramine metabolites.
    Glick SD; Haskew RE; Maisonneuve IM; Carlson JN; Jerussi TP
    Eur J Pharmacol; 2000 May; 397(1):93-102. PubMed ID: 10844103
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of sibutramine on macronutrient selection in male and female rats.
    LeBlanc M; Thibault L
    Physiol Behav; 2003 Nov; 80(2-3):243-52. PubMed ID: 14637222
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuropharmacology of human appetite expression.
    Halford JC; Harrold JA
    Dev Disabil Res Rev; 2008; 14(2):158-64. PubMed ID: 18646016
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Brain activity in hunger and satiety: an exploratory visually stimulated FMRI study.
    Führer D; Zysset S; Stumvoll M
    Obesity (Silver Spring); 2008 May; 16(5):945-50. PubMed ID: 18292747
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Behavioral satiety sequence (BSS) for the diagnosis of drug action on food intake.
    Halford JC; Wanninayake SC; Blundell JE
    Pharmacol Biochem Behav; 1998 Oct; 61(2):159-68. PubMed ID: 9738531
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bran fibers and satiety in women who do not exhibit restrained eating.
    Korczak R; Lindeman K; Thomas W; Slavin JL
    Appetite; 2014 Sep; 80():257-63. PubMed ID: 24874565
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cortical and limbic activation during viewing of high- versus low-calorie foods.
    Killgore WD; Young AD; Femia LA; Bogorodzki P; Rogowska J; Yurgelun-Todd DA
    Neuroimage; 2003 Aug; 19(4):1381-94. PubMed ID: 12948696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.